![]() |
Magna International Inc. 337 Magna Drive Aurora, Ontario L4G 7K1 Tel (905) 726-2462 Fax (905) 726-7164 |
• | Evaluated the effectiveness of certain controls over the Company’s inventory count processes at select locations, including internal controls related to the physical counting of inventories at those locations; |
• | Analyzed locations with inventories to determine where to attend the Company’s physical inventory counts; |
• | With the assistance of specialists with expertise in inventories, determined the nature, timing and extent of procedures to be performed based on the timing of the Company’s physical inventory count procedures, which included: |
• | On a sample basis, performing test counts and comparing the results to the Company’s inventory records; |
• | For annual physical inventory counts which took place at a date other than year-end, performing incremental procedures on the roll-forward period; |
• | With the assistance of specialists in IT, evaluated the general IT controls and automated controls relevant to the inventory management systems; |
• | Evaluated the overall sufficiency of audit evidence obtained over the existence of inventories. |
/s/ Deloitte LLP |
Chartered Professional Accountants |
Licensed Public Accountants |
Toronto, Canada |
February 26, 2023 |
/s/ Deloitte LLP |
Chartered Professional Accountants |
Licensed Public Accountants |
Toronto, Canada |
February 26, 2023 |
Note |
2022 |
2021 | ||||||||||
Sales |
$ |
$ | ||||||||||
|
|
|
|
|||||||||
Costs and expenses |
||||||||||||
Cost of goods sold |
|
|||||||||||
Depreciation and amortization |
|
|||||||||||
Selling, general and administrative |
|
|||||||||||
Interest expense, net |
13 | |||||||||||
Equity income |
|
( |
) |
( |
) | |||||||
Other expense, net |
2 | |||||||||||
|
|
|
|
|||||||||
Income from operations before income taxes |
|
|||||||||||
Income taxes |
9 | |||||||||||
|
|
|
|
|||||||||
Net income |
|
|||||||||||
Income attributable to non-controlling interests |
|
( |
) |
( |
) | |||||||
|
|
|
|
|||||||||
Net income attributable to Magna International Inc. |
|
$ |
$ | |||||||||
|
|
|
|
|||||||||
Earnings per Common Share: |
3 | |||||||||||
Basic |
|
$ |
$ | |||||||||
Diluted |
|
$ |
$ | |||||||||
|
|
|
|
|||||||||
Weighted average number of Common Shares outstanding during the year [in millions]: |
3 | |||||||||||
Basic |
|
|||||||||||
Diluted |
|
|||||||||||
|
|
|
|
Note |
2022 |
2021 | ||||||||||
Net income |
$ |
$ | ||||||||||
Other comprehensive (loss) income, net of tax: |
18 | |||||||||||
Net unrealized loss on translation of net investment in foreign operations |
( |
) |
( |
) | ||||||||
Net unrealized gain on cash flow hedges |
||||||||||||
Reclassification of net gain on cash flow hedges to net income |
( |
) |
( |
) | ||||||||
Reclassification of net loss on pensions to net income |
||||||||||||
Reclassification of loss on translation of net investment in foreign operations to income |
||||||||||||
Pension and post-retirement benefits |
||||||||||||
Other comprehensive loss |
( |
) |
( |
) | ||||||||
Comprehensive income |
||||||||||||
Comprehensive income attributable to non-controlling interests |
( |
) |
( |
) | ||||||||
Comprehensive income attributable to Magna International Inc. |
$ |
$ | ||||||||||
Note |
2022 |
2021 | ||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
4 | $ |
$ | |||||||||
Accounts receivable |
||||||||||||
Inventories |
5 | |||||||||||
Prepaid expenses and other |
||||||||||||
Investments |
6 | |||||||||||
Fixed assets, net |
7 | |||||||||||
Operating lease right-of-use |
14 | |||||||||||
Goodwill |
8 | |||||||||||
Intangible assets, net |
10 | |||||||||||
Deferred tax assets |
9 | |||||||||||
Other assets |
11,15 | |||||||||||
$ |
$ | |||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||||||
Current liabilities |
||||||||||||
Short-term borrowing |
$ |
$ | ||||||||||
Accounts payable |
||||||||||||
Other accrued liabilities |
12 | |||||||||||
Accrued salaries and wages |
||||||||||||
Income taxes payable |
||||||||||||
Long-term debt due within one year |
13 | |||||||||||
Current portion of operating lease liabilities |
14 | |||||||||||
Long-term debt |
13 | |||||||||||
Operating lease liabilities |
14 | |||||||||||
Long-term employee benefit liabilities |
15 | |||||||||||
Other long-term liabilities |
16 | |||||||||||
Deferred tax liabilities |
9 | |||||||||||
Shareholders’ equity |
||||||||||||
Common Shares [issued: 2022 – |
17 | |||||||||||
Contributed surplus |
||||||||||||
Retained earnings |
||||||||||||
Accumulated other comprehensive loss |
18 | ( |
) |
( |
) | |||||||
Non-controlling interests |
||||||||||||
$ |
$ | |||||||||||
/s/ “Peter Bowie” |
/s/ “Robert F. MacLellan” | |||
Director | Chairman of the Board |
Note |
2022 |
2021 | ||||||||||
OPERATING ACTIVITIES |
||||||||||||
Net income |
$ |
$ | ||||||||||
Items not involving current cash flows |
4 | |||||||||||
Changes in operating assets and liabilities |
4 | ( |
) |
( |
) | |||||||
Cash provided from operating activities |
||||||||||||
INVESTMENT ACTIVITIES |
||||||||||||
Fixed asset additions |
( |
) |
( |
) | ||||||||
Increase in investments, other assets and intangible assets |
( |
) |
( |
) | ||||||||
Increase in public and private equity investments |
( |
) |
( |
) | ||||||||
Business combinations |
( |
) |
( |
) | ||||||||
Proceeds on (funding for) disposal of facilities |
2 | ( |
) | |||||||||
Proceeds from dispositions |
||||||||||||
Increase in equity method investments |
— |
( |
) | |||||||||
Settlement of long-term receivable from non-consolidated joint venture |
— |
|||||||||||
Cash used for investing activities |
( |
) |
( |
) | ||||||||
FINANCING ACTIVITIES |
||||||||||||
Issues of debt |
13 | |||||||||||
Increase (decrease) in short-term borrowings |
( |
) | ||||||||||
Repayments of debt |
13 | ( |
) |
( |
) | |||||||
Issue of Common Shares on exercise of stock options |
||||||||||||
Tax withholdings on vesting of equity awards |
( |
) |
( |
) | ||||||||
Repurchase of Common Shares |
17 | ( |
) |
( |
) | |||||||
Contributions to subsidiaries by non-controlling interests |
||||||||||||
Dividends paid to non-controlling interests |
( |
) |
( |
) | ||||||||
Dividends paid |
( |
) |
( |
) | ||||||||
Cash used for financing activities |
( |
) |
( |
) | ||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents |
( |
) |
||||||||||
Net decrease in cash and cash equivalents during the year |
( |
) |
( |
) | ||||||||
Cash, cash equivalents and restricted cash equivalents beginning of year |
||||||||||||
Cash and cash equivalents, end of year |
4 | $ |
$ | |||||||||
Common Shares |
Contri- buted Surplus |
Retained Earnings |
AOCL [i] |
Non- controlling Interests |
Total Equity |
|||||||||||||||||||||||
Number |
Stated Value |
|||||||||||||||||||||||||||
[in millions] |
||||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive (loss) income |
( |
) | ( |
) | ||||||||||||||||||||||||
Contribution by non-controlling interests |
||||||||||||||||||||||||||||
Shares issued on exercise of stock options |
( |
) | ||||||||||||||||||||||||||
Release of stock and stock units |
( |
) | — | |||||||||||||||||||||||||
Tax withholdings on vesting of equity awards |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Repurchase and cancellation under normal course issuer bids [note 17] |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Business combinations |
||||||||||||||||||||||||||||
Dividends paid to non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
Dividends paid [$ |
( |
) | ( |
) | ||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Contribution by non-controlling interests |
||||||||||||||||||||||||||||
Purchase of non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
Shares issued on exercise of stock options |
( |
) | ||||||||||||||||||||||||||
Release of stock and stock units |
( |
) | — | |||||||||||||||||||||||||
Tax withholdings on vesting of equity awards |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Repurchase and cancellation under normal course issuer bids [note 17] |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Business combinations |
||||||||||||||||||||||||||||
Dividends paid to non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
Dividends paid [$ |
( |
) | ( |
) | ||||||||||||||||||||||||
Balance, December 31, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
(i) |
AOCL is Accumulated Other Comprehensive Loss. |
2022 |
2021 | |||||||
Impairments related to operations in Russia [a] |
$ |
$ | — | |||||
Net losses on investments [b] |
||||||||
Loss on sale of business [c] |
||||||||
Restructuring and impairments [d] |
||||||||
Merger agreement termination fee [e] |
— |
( |
) | |||||
Gain on business combinations [f] |
— |
( |
) | |||||
Other expense, net |
$ |
$ | ||||||
[a] |
Impairments related to operations in Russia |
[b] |
Net losses (gains) on investments |
2022 |
2021 | |||||||
Revaluation of public company warrants |
$ |
$ | ( |
) | ||||
Revaluation of public and private equity investments |
||||||||
Net gain on sale of public equity investments |
( |
) |
— | |||||
Other expense, net |
||||||||
Tax effect |
( |
) |
||||||
Net loss attributable to Magna |
$ |
$ | ||||||
[c] |
Loss on sale of business |
[d] |
Restructuring and impairments |
[e] |
Merger agreement termination fee |
[f] |
Gain on business combinations |
2022 |
2021 | |||||||
Basic earnings per Common Share: |
||||||||
Net income attributable to Magna International Inc. |
$ |
$ | ||||||
Weighted average number of Common Shares outstanding during the year |
||||||||
Basic earnings per Common Share |
$ |
$ | ||||||
Diluted earnings per Common Share [a]: |
||||||||
Net income attributable to Magna International Inc. |
$ |
$ | ||||||
Weighted average number of Common Shares outstanding during the year |
||||||||
Stock options and restricted stock |
||||||||
Diluted earnings per Common Share |
$ |
$ | ||||||
[a] | Diluted earnings per Common Share exclude “in-the-money”. two-class method was excluded from the calculation of earnings per share because the effect would be immaterial. |
[a] | Cash and cash equivalents consist of: |
2022 |
2021 | |||||||
Bank term deposits and bankers’ acceptances |
$ |
$ | |
|||||
Cash |
||||||||
$ |
$ |
|||||||
[b] | Items not involving current cash flows: |
2022 |
2021 | |||||||
Depreciation and amortization |
$ |
$ | |
|||||
Amortization of other assets included in cost of goods sold |
||||||||
Deferred revenue amortization |
( |
) |
( |
) | ||||
Other non-cash charges |
||||||||
Deferred tax recovery |
( |
) |
( |
) | ||||
Equity income (in excess of) less than dividends received |
( |
) |
||||||
Non-cash portion of Other expense, net [note 2] |
||||||||
Impairment charges |
— | |||||||
$ |
$ | |||||||
[c] | Changes in operating assets and liabilities: |
2022 |
2021 | |||||||
Accounts receivable |
$ |
( |
) |
$ | ||||
Inventories |
( |
) |
( |
) | ||||
Prepaid expenses and other |
( |
) |
( |
) | ||||
Accounts payable |
|
|||||||
Accrued salaries and wages |
||||||||
Other accrued liabilities |
||||||||
Income taxes (receivable) payable |
( |
) |
||||||
$ |
( |
) |
$ | ( |
) | |||
2022 |
2021 | |||||||
Raw materials and supplies |
$ |
$ | ||||||
Work-in-process |
||||||||
Finished goods |
||||||||
Tooling and engineering |
||||||||
$ |
$ | |||||||
2022 |
2021 | |||||||
Equity method investments [a] |
$ |
$ | ||||||
Public and private equity investments |
||||||||
Warrants [b] |
||||||||
$ |
$ | |||||||
[a] | The ownership percentages and carrying values of the Company’s principal equity method investments at December 31 were as follows [in millions, except percentages]: |
2022 |
2021 | |||||||||||
LG Magna e-Powertrain Co., Ltd. [i] |
% |
$ |
$ | |||||||||
Litens Automotive Partnership [ii] |
% |
$ |
$ | |||||||||
Hubei HAPM Magna Seating Systems Co., Ltd. |
% |
$ |
$ |
[i] | LG Magna e-Powertrain [“LGM”] is a variable interest entity [‘‘VIE’’] and depends on the Company and LG Electronics for any additional cash needs. The Company cannot make key operating decisions considered to be most significant to the VIE, and is therefore not considered to be the primary beneficiary. The Company’s known maximum exposure to loss approximated the carrying value of its investment balance as at December 31, 2022. |
[ii] | The Company accounts for its investments under the equity method of accounting as a result of significant participating rights that prevent control. |
[b] | In October 2020, the Company signed agreements with Fisker Inc. [“Fisker”] for the platform sharing, engineering and manufacturing of the Fisker Ocean SUV. In connection with the arrangement, Fisker issued approximately |
2022 |
2021 | |||||||
Current assets |
$ |
$ | ||||||
Non-current assets |
$ |
$ | |
|||||
Current liabilities |
$ |
$ | ||||||
Long-term liabilities |
$ |
$ | ||||||
2022 |
2021 | |||||||
Sales |
$ |
$ | |
|||||
Cost of goods sold & expenses |
||||||||
Net income |
$ |
$ | ||||||
2022 |
2021 | |||||||
Cost |
||||||||
Land |
$ |
$ | ||||||
Buildings |
||||||||
Machinery and equipment |
||||||||
Accumulated depreciation |
||||||||
Buildings |
( |
) | ( |
) | ||||
Machinery and equipment |
( |
) |
( |
) | ||||
$ |
$ | |
||||||
Body Exteriors & Structures |
Power & Vision |
Seating Systems |
Complete Vehicles |
Corporate |
Total |
|||||||||||||||||||
Balance, December 31, 2020 |
||||||||||||||||||||||||
Acquisitions |
||||||||||||||||||||||||
Foreign exchange and other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Balance, December 31, 2021 |
||||||||||||||||||||||||
Acquisitions |
||||||||||||||||||||||||
Foreign exchange and other |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||
Balance, December 31, 2022 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
[a] | The provision for income taxes differs from the expense that would be obtained by applying the Canadian statutory income tax rate as a result of the following: |
2022 |
2021 | |||||||
Canadian statutory income tax rate |
% |
% | ||||||
Net effect of losses not benefited |
||||||||
Tax on repatriation of foreign earnings |
||||||||
Impairment of investments [note 2] |
||||||||
Foreign rate differentials |
( |
) | ||||||
Reserve for uncertain tax positions |
( |
) | ||||||
Foreign exchange re-measurement [i] |
( |
) |
||||||
Re-measurement of deferred tax assets [ii] |
( |
) |
||||||
Earnings of equity accounted investees |
( |
) |
( |
) | ||||
Valuation allowance on deferred tax assets |
( |
) |
( |
) | ||||
Deductible inflationary adjustments |
( |
) |
( |
) | ||||
Research and development tax credits |
( |
) |
( |
) | ||||
Others |
( |
) | ||||||
Effective income tax rate |
% |
% | ||||||
[i] | Includes foreign exchange gains reported on U.S. dollar denominated assets for Mexican tax purposes that are not recognized for GAAP purposes and losses related to the re-measurement of financial statement balances of foreign subsidiaries, primarily in Mexico, that are maintained in a currency other than their functional currency. |
[ii] | Includes the re-measurement of deferred tax assets of certain European subsidiaries in 2022 and a Chinese subsidiary in 2021. |
[b] | The details of income before income taxes by jurisdiction are as follows: |
2022 |
2021 | |||||||
Canadian |
$ |
( |
) |
$ | ||||
Foreign |
||||||||
$ |
$ | |
||||||
[c] | The details of the income tax provision are as follows: |
2022 |
2021 | |||||||
Current |
||||||||
Canadian |
$ |
$ | ||||||
Foreign |
||||||||
Deferred |
||||||||
Canadian |
( |
) |
( |
) | ||||
Foreign |
( |
) |
( |
) | ||||
( |
) |
( |
) | |||||
$ |
$ | |||||||
[d] | Deferred income taxes have been provided on temporary differences, which consist of the following: |
2022 |
2021 | |||||||
Liabilities currently not deductible for tax |
$ |
$ | ||||||
Net tax losses benefited |
( |
) | ||||||
Re-measurement of deferred tax assets |
( |
) |
||||||
Change in valuation allowance on deferred tax assets |
( |
) |
( |
) | ||||
Tax depreciation (less than) in excess of book depreciation |
( |
) |
( |
) | ||||
Tax on undistributed foreign earnings |
( |
) |
||||||
Unrealized (loss) gain on remeasurement of investments |
( |
) |
||||||
Book amortization in excess of tax amortization |
( |
) |
( |
) | ||||
Others |
( |
) |
( |
) | ||||
$ |
( |
) |
$ | ( |
) | |||
[e] | Deferred tax assets and liabilities consist of the following temporary differences: |
2022 |
2021 | |||||||
Assets |
||||||||
Tax benefit of loss carryforwards |
$ |
$ | ||||||
Operating lease liabilities |
||||||||
Liabilities currently not deductible for tax |
||||||||
Tax credit carryforwards |
||||||||
Other assets tax value in excess of book values |
||||||||
Unrealized loss on foreign exchange hedges and retirement liabilities |
||||||||
Unrealized losses on remeasurement of investments |
||||||||
Others |
||||||||
Valuation allowance against tax benefit of loss carryforwards |
( |
) |
( |
) | ||||
Other valuation allowance |
( |
) |
( |
) | ||||
$ |
$ | |||||||
Liabilities |
||||||||
Operating lease right-of-use |
||||||||
Tax depreciation in excess of book depreciation |
||||||||
Tax on undistributed foreign earnings |
||||||||
Unrealized gain on foreign exchange hedges and retirement liabilities |
||||||||
Unrealized gain on remeasurement of investments |
||||||||
Other assets book value in excess of tax values |
||||||||
Net deferred tax assets (liabilities) |
$ |
$ | ( |
) | ||||
2022 |
2021 | |||||||
Long-term deferred tax assets |
$ |
$ | ||||||
Long-term deferred tax liabilities |
( |
) |
( |
) | ||||
$ |
$ | ( |
) | |||||
[f] | Deferred income taxes have not been provided on $ |
[g] | Income taxes paid in cash [net of refunds] were $ |
[h] | As of December 31, 2022, the Company had domestic and foreign operating loss carryforwards of $ |
[i] | As at December 31, 2022 and 2021, the Company’s gross unrecognized tax benefits were $ |
2022 |
2021 | |||||||
Balance, beginning of year |
$ |
$ | ||||||
Increase based on tax positions related to current year |
||||||||
(Decrease) Increase based on tax positions of prior years |
( |
) |
||||||
Settlements |
( |
) |
( |
) | ||||
Foreign currency translation |
( |
) |
( |
) | ||||
Statute expirations |
( |
) |
( |
) | ||||
$ | $ | |||||||
Remaining weighted average useful life in years |
2022 |
2021 | ||||||||||
Cost |
||||||||||||
Customer relationship intangibles |
$ |
$ | ||||||||||
Computer software |
||||||||||||
Patents and licenses |
||||||||||||
Accumulated depreciation |
||||||||||||
Customer relationship intangibles |
( |
) |
( |
) | ||||||||
Computer software |
( |
) |
( |
) | ||||||||
Patents and licenses |
( |
) |
( |
) | ||||||||
$ |
$ | |||||||||||
2022 |
2021 | |||||||
Preproduction costs related to long-term supply agreements |
$ |
$ | ||||||
Long-term receivables |
||||||||
Unrealized gain on cash flow hedges [note 19] |
||||||||
Pension overfunded status [note 15[a]] |
||||||||
Other |
||||||||
$ |
$ | |||||||
2022 |
2021 | |||||||
Balance, beginning of year |
$ |
$ | ||||||
Expense, net |
||||||||
Settlements |
( |
) |
( |
) | ||||
Business combination |
||||||||
Foreign exchange and other |
( |
) |
( |
) | ||||
$ |
$ | |||||||
[a] | The Company’s long-term debt, net of unamortized issuance costs, is substantially uncollateralized and consists of the following: |
2022 |
2021 | |||||||
Senior Notes [note 13 [c]] |
||||||||
Cdn$ |
$ |
$ | ||||||
€ |
||||||||
$ |
||||||||
$ |
||||||||
€ |
||||||||
$ |
||||||||
Bank term debt at a weighted average interest rate of approximately |
||||||||
Government loans at a weighted average interest rate of approximately |
||||||||
Other |
||||||||
Less due within one year |
||||||||
$ |
$ | |||||||
[b] | Future principal repayments on long-term debt are estimated to be as follows: |
2023 |
$ | |||
2024 |
||||
2025 |
||||
2026 |
||||
2027 |
||||
Thereafter |
||||
$ | ||||
[c] | All of the Senior Notes pay a fixed rate of interest semi-annually except for the € |
[d] | On May 18, 2022, the Company amended its $ 24, 2027 |
[e] | Interest expense, net includes: |
2022 |
2021 | |||||||
Interest expense |
||||||||
Current |
$ | $ | ||||||
Long-term |
||||||||
Interest income |
( |
) | ( |
) | ||||
Interest expense, net |
$ | $ | ||||||
[f] | Interest paid in cash was $ |
2022 |
2021 | |||||||
Operating lease expense |
$ |
$ | ||||||
Short-term lease expense |
||||||||
Variable lease expense |
||||||||
Total lease expense |
$ |
$ | ||||||
2022 |
2021 | |||||||
Operating cash flows – cash paid |
$ |
$ | ||||||
New right-of-use |
$ |
$ | ||||||
Weighted-average remaining lease term |
||||||||
Weighted-average discount rate |
% |
% |
2022 |
2021 | |||||||
2023 |
$ |
$ | ||||||
2024 |
||||||||
2025 |
||||||||
2026 |
||||||||
2027 |
||||||||
2028 and thereafter |
||||||||
Less: amount representing interest |
||||||||
Total lease liabilities |
$ |
$ | ||||||
Current operating liabilities |
$ |
$ | ||||||
Non-current operating lease liabilities |
||||||||
Total lease liabilities |
$ |
$ | ||||||
2022 |
2021 | |||||||
Defined benefit pension plans and other [a] |
$ | $ | ||||||
Termination and long-term service arrangements [b] |
||||||||
Retirement medical benefits plans [c] |
||||||||
Other long-term employee benefits |
||||||||
Long-term employee benefit obligations |
$ | $ | ||||||
[a] |
Defined benefit pension plans |
2022 |
2021 | |||||||
Projected benefit obligation |
||||||||
Discount rate |
% |
% | ||||||
Rate of compensation increase |
% |
% | ||||||
Net periodic benefit cost |
||||||||
Discount rate |
% |
% | ||||||
Rate of compensation increase |
% |
% | ||||||
Expected return on plan assets |
% |
% |
2022 |
2021 | |||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ | ||||||
Current service cost |
||||||||
Interest cost |
||||||||
Actuarial gains and changes in actuarial assumptions |
( |
) |
( |
) | ||||
Benefits paid |
( |
) |
( |
) | ||||
Divestiture |
||||||||
Foreign exchange |
( |
) |
( |
) | ||||
End of year |
||||||||
Plan assets at fair value [i] |
||||||||
Beginning of year |
||||||||
Return on plan assets |
( |
) |
||||||
Employer contributions |
||||||||
Benefits paid |
( |
) |
( |
) | ||||
Foreign exchange |
( |
) |
||||||
End of year |
||||||||
Ending funded status – Plan deficit |
$ |
$ | ||||||
Amounts recorded in the consolidated balance sheet |
||||||||
Non-current asset [note 11] |
$ |
( |
) |
$ | ( |
) | ||
Current liability |
||||||||
Non-current liability |
||||||||
Net amount |
$ |
$ | ||||||
Amounts recorded in accumulated other comprehensive income Unrecognized actuarial losses |
$ |
( |
) |
$ | ( |
) | ||
Net periodic benefit cost |
||||||||
Current service cost |
$ |
$ | ||||||
Interest cost |
||||||||
Return on plan assets |
( |
) |
( |
) | ||||
Actuarial losses |
||||||||
Net periodic benefit cost |
$ |
$ | ||||||
[i] | The asset allocation of the Company’s defined benefit pension plans at December 31, 2022 and the target allocation range for 2023 is as follows: |
2023 |
2022 | |||||||
Fixed income securities |
% |
% | ||||||
Equity securities |
% |
% | ||||||
Cash and cash equivalents |
% |
% | ||||||
% |
% | |||||||
[b] |
Termination and long-term service arrangements |
2022 |
2021 | |||||||
Discount rate |
% |
% | ||||||
Rate of compensation increase |
% |
% |
2022 |
2021 | |||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ | ||||||
Current service cost |
||||||||
Interest cost |
||||||||
Actuarial losses (gains) and changes in actuarial assumptions |
( |
) |
||||||
Benefits paid |
( |
) |
( |
) | ||||
Foreign exchange |
( |
) |
( |
) | ||||
Ending funded status – Plan deficit |
$ |
$ | ||||||
Amounts recorded in the consolidated balance sheet |
||||||||
Current liability |
$ |
$ | ||||||
Non-current liability |
||||||||
Net amount |
$ |
$ | ||||||
Amounts recorded in accumulated other comprehensive income Unrecognized actuarial losses |
$ |
( |
) |
$ | ( |
) | ||
Net periodic benefit cost |
||||||||
Current service cost |
$ |
$ | ||||||
Interest cost |
||||||||
Actuarial losses |
||||||||
Net periodic benefit cost |
$ |
$ | ||||||
[c] |
Retirement medical benefits plans |
2022 |
2021 | |||||||
Retirement medical benefit obligations |
% |
% | ||||||
Net periodic benefit cost |
% |
% | ||||||
Health care cost inflation |
% |
% | ||||||
2022 |
2021 | |||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ | ||||||
Interest cost |
||||||||
Actuarial gains and changes in actuarial assumptions |
( |
) |
( |
) | ||||
Benefits paid |
( |
) |
( |
) | ||||
Ending funded status – Plan deficit |
$ |
$ | ||||||
Amounts recorded in the consolidated balance sheet |
||||||||
Current liability |
$ |
$ | ||||||
Non-current liability |
||||||||
Net amount |
$ |
$ | ||||||
Amounts recorded in accumulated other comprehensive income Unrecognized actuarial gains |
$ |
$ | ||||||
Net periodic benefit cost |
||||||||
Interest cost |
$ |
$ | ||||||
Actuarial gains |
( |
) |
( |
) | ||||
Net periodic benefit cost |
$ |
$ | ||||||
[d] |
Future benefit payments |
Defined benefit pension plans |
Termination and long service arrangements |
Retirement medical benefits plans |
Total | |||||||||||||
Expected employer contributions - 2023 |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Expected benefit payments: |
||||||||||||||||
2023 |
$ | $ | $ | $ | ||||||||||||
2024 |
||||||||||||||||
2025 |
||||||||||||||||
2026 |
||||||||||||||||
2027 |
||||||||||||||||
Thereafter |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |
||||||||||||
|
|
|
|
|
|
|
|
2022 |
2021 | |||||||
Long-term portion of income taxes payable |
$ |
$ | |
|||||
Long-term portion of deferred revenue |
||||||||
Asset retirement obligation |
||||||||
Long-term portion of fair value of hedges [note 19] |
||||||||
Other |
||||||||
|
|
|
|
|||||
$ |
$ | |
||||||
|
|
|
|
[a] | At December 31, 2022, the Company’s authorized, issued and outstanding capital stock are as follows: |
[i] | Each share is entitled to |
[ii] | Each share shall participate equally as to dividends. |
[b] | On November 9, 2022, the Toronto Stock Exchange [“TSX”] accepted the Company’s Notice of Intention to make a Normal Course Issuer Bid relating to the purchase for cancellation, as well as purchases to fund the Company’s stock-based compensation awards or programs and/or the Company’s obligations to its deferred profit sharing plans, of up to |
2022 |
2021 | |||||||||||||||
Shares purchased |
Cash amount |
Shares purchased |
Cash amount |
|||||||||||||
2020 Bid |
$ | $ | ||||||||||||||
2021 Bid |
||||||||||||||||
2022 Bid |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ |
$ | |||||||||||||||
|
|
|
|
|
|
|
|
[c] | The following table presents the maximum number of shares that would be outstanding if all the dilutive instruments outstanding at February 26, 2023 were exercised or converted: |
Common Shares |
||||
Stock options [i] |
||||
|
|
|||
|
|
[i] | |
2022 |
2021 | |||||||
Accumulated net unrealized loss on translation of net investment in foreign operations |
||||||||
Balance, beginning of year |
$ |
( |
) |
$ | ( |
) | ||
Net unrealized loss |
( |
) |
( |
) | ||||
Recognition of CTA loss in Russia |
— | |||||||
Repurchase of shares under normal course issuer bids [note 17] |
||||||||
Balance, end of year |
( |
) |
( |
) | ||||
Accumulated net unrealized gain on cash flow hedges [b] |
||||||||
Balance, beginning of year |
||||||||
Net unrealized gains |
||||||||
Reclassification of net gain to net income [a] |
( |
) |
( |
) | ||||
Balance, end of year |
||||||||
Accumulated net unrealized loss on other long-term liabilities [b] |
||||||||
Balance, beginning of year |
( |
) |
( |
) | ||||
Net unrealized gains |
||||||||
Reclassification of net loss to net income [a] |
||||||||
Balance, end of year |
( |
) |
( |
) | ||||
Total accumulated other comprehensive loss [c] |
$ |
( |
) |
$ | ( |
) | ||
[a] | The effects on net income of amounts reclassified from AOCL, with presentation location, were as follows: |
2022 |
2021 | |||||||
Cash flow hedges |
||||||||
Sales |
$ |
( |
) |
$ | ||||
Cost of sales |
||||||||
Income tax |
( |
) |
( |
) | ||||
Net of tax |
||||||||
Other long-term liabilities |
||||||||
Cost of sales |
( |
) |
( |
) | ||||
Income tax |
||||||||
Net of tax |
( |
) |
( |
) | ||||
Total gain reclassified to net income |
$ |
$ | ||||||
[b] | The amount of income tax benefit that has been allocated to each component of other comprehensive loss is as follows: |
2022 |
2021 | |||||||
Accumulated net unrealized loss on translation of net investment in foreign operations |
$ |
$ | ||||||
Accumulated net unrealized gain on cash flow hedges |
||||||||
Balance, beginning of year |
( |
) |
( |
) | ||||
Net unrealized gain (loss) |
( |
) | ||||||
Reclassification of net loss to net income |
||||||||
Balance, end of year |
( |
) | ||||||
Accumulated net unrealized loss on other long-term liabilities |
||||||||
Balance, beginning of year |
||||||||
Net unrealized loss |
( |
) |
( |
) | ||||
Reclassification of net gain to net income |
( |
) |
( |
) | ||||
Balance, end of year |
||||||||
Total income tax benefit |
$ |
$ | ||||||
[c] | The amount of other comprehensive gain that is expected to be reclassified to net income during 2023 is $ |
[a] |
Foreign exchange contracts |
For Canadian dollars | For U.S. dollars | For euros | ||||||||||||||||||||||||||||||
Buy (Sell) |
U.S. dollar amount |
Weighted average rate |
Peso amount |
Weighted average rate |
U.S dollar amount |
Weighted average rate |
Czech Koruna amount |
Weighted average rate |
||||||||||||||||||||||||
2023 |
||||||||||||||||||||||||||||||||
2023 |
( |
) | ( |
) | ( |
) | — | — | ||||||||||||||||||||||||
2024 |
||||||||||||||||||||||||||||||||
2024 |
( |
) | — | ( |
) | — | — | |||||||||||||||||||||||||
2025 |
— | — | ||||||||||||||||||||||||||||||
2025 |
( |
) | — | — | ( |
) | — | — | ||||||||||||||||||||||||
2026 |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
2026 |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||
( |
) | ( |
) | |||||||||||||||||||||||||||||
[b] |
Financial assets and liabilities |
2022 |
2021 | |||||||
Financial assets |
||||||||
Cash and cash equivalents |
$ |
$ | ||||||
Accounts receivable |
||||||||
Warrants and public and private equity investments |
||||||||
Long-term receivables included in other assets [note 11] |
||||||||
$ |
$ | |||||||
Financial liabilities |
||||||||
Bank Indebtedness |
$ |
$ | — | |||||
Long-term debt (including portion due within one year) |
||||||||
Accounts payable |
||||||||
$ |
$ | |||||||
Derivatives designated as effective hedges, measured at fair value |
||||||||
Foreign currency contracts |
||||||||
Prepaid expenses |
$ |
$ | ||||||
Other assets |
||||||||
Other accrued liabilities |
( |
) |
( |
) | ||||
Other long-term liabilities |
( |
) |
( |
) | ||||
$ |
$ | |||||||
[c] |
Derivatives designated as effective hedges, measured at fair value |
Gross amounts presented in consolidated balance sheets |
Gross amounts not offset in consolidated balance sheets |
Net amounts |
||||||||||
December 31, 2022 |
||||||||||||
Assets |
$ |
$ |
$ |
|||||||||
Liabilities |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
December 31, 2021 |
||||||||||||
Assets |
$ | $ | $ | |||||||||
Liabilities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
[d] |
Fair value |
[e] |
Credit risk |
[f] |
Currency risk |
[g] |
Interest rate risk |
[h] |
Equity price risk |
[a] | Magna is a global automotive supplier which has complete vehicle engineering and contract manufacturing expertise, as well as product capabilities which include body, chassis, exterior, seating, powertrain, active driver assistance, electronics, mirrors & lighting, mechatronics and roof systems. Magna also has electronic and software capabilities across many of these areas. |
[a] | The following tables show segment information for the Company’s reporting segments and a reconciliation of Adjusted EBIT to the Company’s consolidated income before income taxes: |
2022 |
||||||||||||||||||||
Total sales |
External sales |
Adjusted EBIT |
Depreciation and amortization |
Equity loss (income) |
||||||||||||||||
Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Power & Vision |
( |
) | ||||||||||||||||||
Seating Systems |
( |
) | ||||||||||||||||||
Complete Vehicles |
( |
) | ||||||||||||||||||
Corporate & Other [i] |
( |
) |
||||||||||||||||||
Total Reportable Segments |
$ |
$ |
$ |
$ |
$ |
( |
) | |||||||||||||
2021 | ||||||||||||||||||||
Total sales |
External sales |
Adjusted EBIT |
Depreciation and amortization |
Equity loss (income) |
||||||||||||||||
Body Exteriors & Structures |
$ | $ | $ | $ | $ | |||||||||||||||
Power & Vision |
( |
) | ||||||||||||||||||
Seating Systems |
( |
) | ||||||||||||||||||
Complete Vehicles |
( |
) | ||||||||||||||||||
Corporate & Other [i] |
( |
) | ( |
) | ||||||||||||||||
Total Reportable Segments |
$ | $ | $ | $ | $ | ( |
) | |||||||||||||
2022 |
||||||||||||||||||||
Net assets |
Investments |
Goodwill |
Fixed assets, net |
Fixed asset additions |
||||||||||||||||
Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Power & Vision |
||||||||||||||||||||
Seating Systems |
||||||||||||||||||||
Complete Vehicles |
||||||||||||||||||||
Corporate & Other |
||||||||||||||||||||
Total Reportable Segments |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
2021 | ||||||||||||||||||||
Net assets |
Investments | Goodwill | Fixed assets, net |
Fixed asset additions |
||||||||||||||||
Body Exteriors & Structures |
$ | $ | $ | $ | $ | |||||||||||||||
Power & Vision |
||||||||||||||||||||
Seating Systems |
||||||||||||||||||||
Complete Vehicles |
||||||||||||||||||||
Corporate & Other |
||||||||||||||||||||
Total Reportable Segments |
$ | $ | $ | $ | $ | |||||||||||||||
[i] | Included in Corporate and Other Adjusted EBIT are intercompany fees charged to the automotive segments. |
[b] | The following table reconciles Net income from operations to Adjusted EBIT: |
2022 |
2021 | |||||||
Net Income |
$ |
$ | ||||||
Add: |
||||||||
Interest expense, net |
||||||||
Other expense, net |
||||||||
Income taxes |
||||||||
Adjusted EBIT |
$ |
$ | ||||||
[c] | The following table shows Net Assets for the Company’s reporting segments: |
2022 |
2021 | |||||||
Total Assets |
$ |
$ | ||||||
Deduct assets not included in segment net assets: |
||||||||
Cash and cash equivalents |
( |
) |
( |
) | ||||
Deferred tax assets |
( |
) |
( |
) | ||||
Long-term receivables from joint venture partners |
( |
) |
( |
) | ||||
Deduct liabilities included in segment net assets: |
||||||||
Accounts payable |
( |
) |
( |
) | ||||
Accrued salaries and wages |
( |
) |
( |
) | ||||
Other accrued liabilities |
( |
) |
( |
) | ||||
Segment Net Assets |
$ |
$ | ||||||
[d] | The following table aggregates external revenues by customer as follows: |
2022 |
2021 | |||||||
General Motors |
$ |
$ | ||||||
BMW |
||||||||
Stellantis |
||||||||
Daimler AG |
||||||||
Ford Motor Company |
||||||||
Volkswagen |
||||||||
Other |
||||||||
$ |
$ |
|||||||
[e] | The following table summarizes external revenues and long-lived assets by geographic region: |
External Sales |
Fixed Assets, Net |
|||||||||||||||
2022 |
2021 | 2022 |
2021 | |||||||||||||
North America |
||||||||||||||||
United States |
$ |
$ | $ |
$ | ||||||||||||
Canada |
||||||||||||||||
Mexico |
||||||||||||||||
Europe |
||||||||||||||||
Austria |
||||||||||||||||
Germany |
||||||||||||||||
Czech Republic |
||||||||||||||||
Poland |
||||||||||||||||
France |
||||||||||||||||
Italy |
||||||||||||||||
Spain |
||||||||||||||||
United Kingdom |
||||||||||||||||
Turkey |
||||||||||||||||
Slovakia |
||||||||||||||||
Russia |
||||||||||||||||
Other Europe |
||||||||||||||||
Asia Pacific |
||||||||||||||||
China |
||||||||||||||||
India |
||||||||||||||||
Other Asia Pacific |
||||||||||||||||
Rest of World |
||||||||||||||||
$ |
$ | $ |
$ | |||||||||||||